Clinical Trials Logo

Cancer, Gastric clinical trials

View clinical trials related to Cancer, Gastric.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06391749 Recruiting - Cancer, Breast Clinical Trials

Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)

K-ACCELERATE
Start date: May 2024
Phase:
Study type: Observational

To evaluate the diagnostic performance of blood-based SPOT-MAS test in symptomatic individuals, the investigators sought to launch a prospective multicenter study, named K-ACCELERATE. The study aims to recruit 1,000 participants who develop symptoms and signs specific to the top five common cancer types including breast, colorectal, gastric, liver and lung cancer. Primary objective: Evaluate the performance of the SPOT-MAS test in detecting cancer in symptomatic populations. Secondary objectives: Evaluate the feasibility of incorporating SPOT-MAS as a triage test into primary care to increase the detection rates of malignant cancer while minimizing unnecessary referrals to invasive procedures.

NCT ID: NCT05227261 Recruiting - Cancer, Breast Clinical Trials

Early Detection of Five Common Cancers Using the ctDNA Analysing Test

K-DETEK
Start date: April 10, 2022
Phase:
Study type: Observational

This is a multi-centre, prospective cohort study, aiming to evaluate a blood test in early detection of the four common cancers, based on the investigation of the circulating tumour DNA (ctDNA). Primary objective: To evaluate the performance characteristics of the blood ctDNA test in early detecting cancers. Secondary objectives: - To evaluate the performance characteristics of the test in determining the origin of tumour, as compared to the findings of the imaging diagnostic tests. - To determine the risk of cancers development in the high-risk population, as compared to that in the moderate-risk group.